Abstract
Background:
Neonatal hyperthyroidism is rare, seen in infants of mothers with Graves’ disease (GD), with transplacental transfer of thyroid-stimulating hormone receptor (TSHR) antibodies (TRAbs). We describe a neonate with severe hyperthyroidism due to TRAbs, born to a mother with autoimmune hypothyroidism.
Case presentation:
A baby boy born preterm at 35 weeks had irritability, tachycardia and proptosis after birth. The mother had autoimmune hypothyroidism, from age 10, with thyroxine replacement and normal thyroid function throughout her pregnancy. She had never been thyrotoxic. There was a family history of Hashimoto’s thyroiditis (HT) and GD. The baby’s thyroid function on day 3 demonstrated gross thyrotoxicosis, TSH<0.01 mIU/L (normal range [NR]<10 mIU/L), free thyroxine (FT4)>77 pmol/L (20–35), free triiodothyronine (FT3) 15.4 pmol/L (4.2–8.3) and TRAb 18.4 IU/L (<1.8). The mother’s TRAb was 24.7 IU/L. Thyrotoxicosis required propranolol and carbimazole (CBZ). Thyroid function normalized within 10 days. The baby was weaned off medication by 7 weeks. He remains euthyroid.
Conclusions:
We postulate that this mother had co-existing destructive thyroiditis and thyroid-stimulating antibodies (TSAbs) and TSHR blocking antibodies (TBAb), rendering her unable to raise a thyrotoxic response to the TSAbs but with predominant TSAb transmission to her infant. Maternal history of any thyroid disorder may increase the risk of transmission to an infant, requiring a careful clinical assessment of the neonate, with important implications for future pregnancies.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. van der Kaay DC, Wasserman JD, Palmert MR. Management of neonates born to mothers with Graves’ disease. Pediatrics 2016;137:e20151878.10.1542/peds.2015-1878Search in Google Scholar
2. McLachlan SM, Rapoport B. Thyrotropin-blocking autoantibodies and thyroid-stimulating autoantibodies: potential mechanisms involved in the pendulum swinging from hypothyroidism to hyperthyroidism or vice versa. Thyroid 2013;23:14–24.10.1089/thy.2012.0374Search in Google Scholar
3. Takasu N, Yamada T, Takasu M, Komiya I, Nagasawa Y, et al. Disappearance of thyrotropin-blocking antibodies and spontaneous recovery from hypothyroidism in autoimmune thyroiditis. N Engl J Med 1992;326:513–8.10.1056/NEJM199202203260803Search in Google Scholar
4. Takasu N, Yamada T, Katakura M, Yamauchi K, Shimizu Y, et al. Evidence for thyrotropin (TSH)-blocking activity in goitrous Hashimoto’s thyroiditis with assays measuring inhibition of TSH receptor binding and TSH-stimulated thyroid adenosine 3′,5′-monophosphate responses/cell growth by immunoglobulins. J Clin Endocrinol Metab 1987;64:239–45.10.1210/jcem-64-2-239Search in Google Scholar
5. Takasu N, Matsushita M. Changes of TSH-stimulation blocking antibody (TSBAb) and thyroid stimulating antibody (TSAb) over 10 years in 34 TSBAb-positive patients with hypothyroidism and in 98 TSAb-positive Graves’ patients with hyperthyroidism: reevaluation of TSBAb and TSAb in TSH-receptor-antibody (TRAb)-positive patients. J Thyroid Res 2012;2012:182176.10.1155/2012/182176Search in Google Scholar
6. Takasu N, Yamada T, Sato A, Nakagawa M, Komiya I, et al. Graves’ disease following hypothyroidism due to Hashimoto’s disease: studies of eight cases. Clin Endocrinol (Oxf) 1990; 33:687–98.10.1111/j.1365-2265.1990.tb03906.xSearch in Google Scholar
7. Kohn LD, Suzuki K, Hoffman WH, Tombaccini D, Marcocci C, et al. Characterization of monoclonal thyroid-stimulating and thyrotropin binding-inhibiting autoantibodies from a Hashimoto’s patient whose children had intrauterine and neonatal thyroid disease. J Clin Endocrinol Metab 1997;82:3998–4009.Search in Google Scholar
8. Chang TC, Lee JS. Pregnancy induces the presence of a thyroid-stimulating antibody in a thyrotropin-binding inhibitory immunoglobulin positive, hypothyroid woman with transient thyrotoxicosis in offspring. J Formos Med Assoc 1990;89: 709–13.Search in Google Scholar
9. Lu R, Burman KD, Jonklaas J. Transient Graves’ hyperthyroidism during pregnancy in a patient with Hashimoto’s hypothyroidism. Thyroid 2005;15:725–9.10.1089/thy.2005.15.725Search in Google Scholar
10. Volpe R, Ehrlich R, Steiner G, Row VV. Graves’ disease in pregnancy years after hypothyroidism with recurrent passive-transfer neonatal Graves’ disease in offspring. Therapeutic considerations. Am J Med 1984;77:572–8.10.1016/0002-9343(84)90125-6Search in Google Scholar
11. Brookfield DS, McCandless AE, Smith CS. Thyrotoxicosis in a neonate of a mother with no history of thyroid disease. Arch Dis Child 1976;51:314–6.10.1136/adc.51.4.314Search in Google Scholar PubMed PubMed Central
12. Kiefer FW, Klebermass-Schrehof K, Steiner M, Worda C, Kasprian G, et al. Fetal/neonatal thyrotoxicosis in a newborn from a hypothyroid woman with Hashimoto thyroiditis. J Clin Endocrinol Metab 2017;102:6–9.Search in Google Scholar
©2018 Walter de Gruyter GmbH, Berlin/Boston
